Fundraising Fox
Cleerly
Denver, US · Founded 2017 · 381 employees on LinkedIn · 19 known investors
Find your way into Cleerly
Each arrow is one introduction. Sign up to fill in the first one.
Ask David J. Kim to introduce you to James Min, MD
You →David · together at Cleerly →James
Sign up to find every way you can get introduced to Cleerly
- Your email: who you already know at Cleerly, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cleerly team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease. Its technology, validated in peer-reviewed clinical trials, is used by healthcare organizations to support personalized treatment decisions in heart care.
Founders & leadership
Cleerly was founded in 2017 by James Min, MD.
Board
Investors · 19
How we know: Battery Ventures's portfolio page · funding news · mpo-mag.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Breyer Capital's portfolio page · cleerlyhealth.com · the VCSheet dataset · Not right? Tell us
How we know: cleerlyhealth.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Esplanade Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Insight Partners's portfolio page · funding news · prnewswire.com · Not right? Tell us
How we know: board seat on SEC Form D · cleerlyhealth.com · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: cleerlyhealth.com · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · cleerlyhealth.com · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 7
Funding
SEC filings, press & company announcements$380.9M disclosed across 5 of 7 rounds · 2017–2025
- Undisclosed amountSeries C extensionJan 2025
Insight Partners (lead), Battery Ventures
Source ↗ - Undisclosed amountSeries CDec 2024Source ↗
- $106MraisedDec 2024 · 3 sources
Insight Partners (lead)
Source ↗
▶$51.3MraisedDec 2024 · 10 investors · Other TechnologyRule 506(b)
- Lee CooperDirector
- Word D. Peake IIIDirector
- Peter Justin KleinDirector
- Scott BarclayDirector
- James K. MinExecutive Officer, Director
- Louis SamsonDirector
- Oscar MunozDirector
- Offering amount
- $106.3M
- Amount sold
- $51.3M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$192.3MraisedJul 2022 · 56 investors · Other TechnologyRule 506(b)
- Word D. PeakeDirector
- Peter Justin KleinDirector
- James K. MinExecutive Officer, Director
- Vijay LathiDirector
- Glenn SteeleDirector
- Roy BeveridgeDirector
- Kevin KingDirector
- Offering amount
- $230M
- Amount sold
- $192.3M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.8MraisedMar 2022 · 25 investors · Other TechnologyRule 506(b)
- James K. MinExecutive Officer, Director
- Word D. PeakeDirector
- Vijay LathiDirector
- Peter Justin KleinDirector
- Kevin KingDirector
- Kristin BinnsExecutive Officer
- Glenn SteeleDirector
- Nick NieslanikExecutive Officer
- Jim HartmanExecutive Officer
- Roy BeveridgeDirector
- James EarlsExecutive Officer
- Offering amount
- $16.8M
- Amount sold
- $16.8M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.5MraisedApr 2020 · 31 investors · Other TechnologyRule 506(b)
- James K. MinExecutive Officer, Director
- Offering amount
- $15.4M
- Amount sold
- $14.5M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Cleerly went on to found or lead other companies.
Frequently asked questions
- What does Cleerly do?
- Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease. Its technology, validated in peer-reviewed clinical trials, is used by healthcare organizations to support personalized treatment decisions in heart care.
- Who founded Cleerly?
- Cleerly was founded by James Min, MD in 2017.
- Who are Cleerly's investors?
- Cleerly's investors include Battery Ventures, Breyer Capital, DigiTx Partners LLC, Esplanade Ventures, Insight Partners, LRVHealth, DCVC (Data Collective), New Leaf Venture Partners and 4 more.
- How much funding has Cleerly raised?
- Cleerly has disclosed $380.9M raised across 5 of its 7 known rounds.
- Where is Cleerly headquartered?
- Cleerly is headquartered in Denver, US.